Washington Trust Advisors’s Sanofi SNY Stock Holding History

Washington Trust Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-884	Closed	-$34K	–	878
2022 Q3	$34K	Sell	884 -156	-15%	-$6.95K	﹤0.01%	444
2022 Q2	$52K	Sell	1,040 -305	-23%	-$16.2K	﹤0.01%	390
2022 Q1	$69K	Sell	1,345 -290	-18%	-$15K	﹤0.01%	396
2021 Q4	$82K	Buy	+1,635	New	+$80.9K	0.01%	393

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Washington Trust Advisors's SNY Position: Q4 2022 in Review

Washington Trust Advisors sold out of Sanofi (SNY) in Q4 2022, closing a stake of 884 shares — an estimated $34K sold.

Washington Trust Advisors first reported a position in SNY in Q4 2021 and held it in 4 quarters. The position peaked at $82K in Q4 2021. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

Washington Trust Advisors reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
Washington Trust Advisors sold 884 Sanofi shares in Q4 2022, an estimated $34K.
Washington Trust Advisors first reported a position in Sanofi in Q4 2021 and held it in 4 quarters.
Washington Trust Advisors's Sanofi position peaked at $82K in Q4 2021.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Washington Trust Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.